Liu Z R, Bull A L, Phuong L K, Malloy M J, Friedman N D, Worth L J
Melbourne Medical School, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.
Victorian Healthcare Associated Infection Surveillance Coordinating Centre, The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
J Hosp Infect. 2025 Jul;161:83-91. doi: 10.1016/j.jhin.2025.04.009. Epub 2025 Apr 26.
Neonates face a high risk of healthcare-associated bloodstream infections, leading to increased morbidity and mortality. Effective surveillance is crucial for safe neonatal care and infection prevention.
To evaluate infection trends, pathogen distribution and antimicrobial resistance patterns in central- and peripheral-line-associated bloodstream infections (CLABSIs and PLABSIs) in Victorian Level 6 neonatal intensive care units between 1 July 2008 and 30 June 2024.
Data were collected by the Victorian Healthcare Associated Infection Surveillance System Coordinating Centre using Centers for Disease Control and Prevention National Healthcare Safety Network guidelines. A retrospective data analysis of prospectively collected data was conducted to examine infection epidemiology.
Overall, 581 neonates developed CLABSIs or PLABSIs, corresponding to a mean CLABSI rate of 2.26 per 1000 central-line-days and a mean PLABSI rate of 0.60 per 1000 peripheral-line-days. The median age at diagnosis of all events was 16 days (interquartile range 9-35 days). No trends were observed in CLASBI or PLABSI rates over the study period. However, an increasing trend in CLABSI rates [incidence risk ratio (IRR) 1.04, 95% confidence interval (CI) 1.00-1.07; P=0.043] and a decreasing trend in PLABSI rates (IRR 0.95, 95% CI 0.92-0.99; P=0.021) were noted among neonates with birth weight ≤750 g. The most frequently reported organisms were coagulase-negative staphylococci, responsible for 44.0% of CLABSIs and 39.5% of PLABSIs.
Neonatal intensive care units in Victoria maintained low CLABSI and PLABSI rates over the study period. Higher infection rates in low-birthweight neonates emphasize the need for targeted infection prevention strategies for this vulnerable population.
新生儿面临较高的医疗保健相关血流感染风险,导致发病率和死亡率增加。有效的监测对于安全的新生儿护理和感染预防至关重要。
评估2008年7月1日至2024年6月30日期间维多利亚州6级新生儿重症监护病房中心静脉导管相关血流感染(CLABSI)和外周静脉导管相关血流感染(PLABSI)的感染趋势、病原体分布和抗菌药物耐药模式。
维多利亚州医疗保健相关感染监测系统协调中心按照疾病控制与预防中心国家医疗安全网络指南收集数据。对前瞻性收集的数据进行回顾性数据分析,以研究感染流行病学。
总体而言,581名新生儿发生了CLABSI或PLABSI,中心静脉导管相关血流感染的平均发生率为每1000个中心静脉导管日2.26例,外周静脉导管相关血流感染的平均发生率为每1000个外周静脉导管日0.60例。所有感染事件的诊断中位年龄为16天(四分位间距9 - 35天)。在研究期间,未观察到CLABSI或PLABSI发生率的趋势。然而,出生体重≤750g的新生儿中,CLABSI发生率呈上升趋势[发病风险比(IRR)1.04,95%置信区间(CI)1.00 - 1.07;P = 0.043],PLABSI发生率呈下降趋势(IRR 0.95,95% CI 0.92 - 0.99;P = 0.021)。最常报告的病原体是凝固酶阴性葡萄球菌,占CLABSI的44.0%和PLABSI的39.5%。
在研究期间,维多利亚州的新生儿重症监护病房维持了较低的CLABSI和PLABSI发生率。低出生体重新生儿较高的感染率凸显了针对这一脆弱人群制定针对性感染预防策略的必要性。